Did you know that Truthout is a nonprofit and independently funded by readers like you? If you value what we do, please support our work with a donation.

An analysis released Friday by Democrats on the congressional Joint Economic Committee details how US President Donald Trump loaded up on shares of major pharmaceutical companies last year as his administration and Republican allies enacted policies that benefited the industry — at the expense seniors and other patients.

The JEC analysis estimates that Trump increased his stock holdings in the pharmaceutical sector from $1.7 million in 2024 to as much as $56.2 million last year. The committee notes that Trump, who has repeatedly promised to cut drug prices while implementing policies that raised them, “held as much as $39.1 million in stock in the same Big Pharma companies that directly benefited” from a budget package that the president signed into law last summer.

“Trump and congressional Republicans intentionally force seniors to pay more for cancer treatment so that Big Pharma can rake in more money that Trump can personally profit from,” said Sen. Maggie Hassan........

© Truthout